NCT00002674View on ClinicalTrials.gov

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 1994

Primary Completion Date

March 31, 2000

Study Completion Date

March 31, 2000

Conditions
Leukemia
Interventions
BIOLOGICAL

filgrastim

DRUG

cytarabine

DRUG

etoposide

DRUG

hydroxyurea

DRUG

mitoxantrone hydrochloride

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

98109

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00002674 - Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter